CoChat
Sign Up
Cited by 261Proteoglycans and glycosaminoglycans researchHydrogels: synthesis, properties, applicationsProtease and Inhibitor Mechanisms

Hyaluronidases in cancer biology

Stern, Robert·2008·Seminars in Cancer Biology
DOI 10.1016/j.semcancer.2008.03.017
Open this paper in CoChat — free account

Abstract

Hyaluronan is a megadalton glycosaminoglycan polymer critical for maintaining the integrity of the extracellular matrix. It can exist in a protein-bound state with aggregating proteoglycans, where it expands the extracellular matrix and modulates cell-cell interactions. It also exists in lower molecular weight forms that participate in a myriad of biological functions. It is unique in that much of it is degraded within hours of its synthesis. High molecular weight hyaluronan, a reflection of intact healthy tissues, is normally produced by hyaluronan synthases at the plasma membrane. It is catabolized by the action of an extracellular plasma membrane-tethered hyaluronidase that is coordinated with intracellular lysosomal hyaluronidases and exoglycosidases. This occurs in local tissues and lymph, with the remainder being cleared by the sinusoidal liver endothelium upon entering the vascular compartment. Elevated extracellular levels of hyaluronan and its partially catabolized oligomers are found in certain malignancies, potentially due to decoupled synthesis and degradation. Furthermore, partially depolymerized hyaluronan in the extracellular environment may have properties not found in the multivalent high molecular weight polymer in malignancies. Functional perturbations of hyaluronan synthesis and degradation have revealed active roles of the synthases and hyaluronidases in epithelial mesenchymal conversion, stroma and vascular formation, interstitial fluid pressure and chemosensitivity. While at least three confirmed hyaluronidases exist in the human genome (HYAL1, HYALl2 and PH20), functional perturbation of these genes in mice have failed to identify a simple linear catabolic circuit. The family of enzymes responsible for the synthesis and degradation of hyaluronan are being characterized. The fragmented forms of hyaluronan, largely a sign of cellular distress, occur in abundance in many malignancies. These small hyaluronan oligomers are assumed to be largely a result of hyaluronidase activity. Precisely how particular-sized fragments are generated and maintained is not known. Presumably, hyaluronan-binding proteins, in addition to the proteoglycans, participate in this process. Hyaluronidase inhibitors are now recognized, as well as growth factors that enhance the synthetic enzymes. A complete understanding of the anabolic and catabolic systems for hyaluronan may provide new dimensions into our understanding of cancer progression, as well as new opportunities for therapeutic intervention.

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2008.03.017

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

4 of the 69 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Related

Authors
Stern, R.
Affiliations
Al-Quds University (PS)
Corresponding author
Stern, Robert
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2008-08
Volume
18
Issue
4
Pages
275-280
ISSN
1044-579X (ISSN-L)
DOI
10.1016/j.semcancer.2008.03.017
OpenAlex
W2067014191
Cited by
261
References
69
Citations by year
2026: 8 · 2025: 6 · 2024: 13 · 2023: 18 · 2022: 14 · 2021: 12 · 2020: 14 · 2019: 16 · 2018: 15 · 2017: 15 · 2016: 18 · 2015: 21 · 2014: 22 · 2013: 13 · 2012: 14
FWCI
1.11
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Seminars in Cancer Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
hyaluronidase, hyaluronic acid, hyaluronan oligosaccharides, extracellular matrix, hyaluronan synthase, cancer, epithelial-mesenchymal transition, tumor stroma, angiogenesis, interstitial fluid pressure, chemosensitivity, HYAL1, HYAL2, hyaluronidase inhibitors, hyaluronan-binding protein
MeSH terms
Animals, Humans, Hyaluronic Acid, Hyaluronoglucosaminidase, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review